News on Medial

Related News

Quadria Group launches HealthQuad Fund III with $300 Mn corpus

EntrackrEntrackr · 1m ago
Quadria Group launches HealthQuad Fund III with $300 Mn corpus
Medial

Quadria Group, a healthcare-focused private equity platform, has announced the launch of HealthQuad Fund III with a proposed raise of up to $300 million (target corpus of $200 million and a $100 million greenshoe option). As the successor to Funds I and II, the third fund aims to build on a proven track record of identifying and scaling pioneering healthcare ventures that have significantly expanded access, affordability, and quality of care across India. The launch aligns with Quadria’s long-term vision of creating India’s most integrated healthcare investment platform, offering capital solutions from early-stage innovation to scaled growth across the healthcare value chain. Launched in 2016, HealthQuad was initiated as a distinct investment vehicle focused on supporting disruptive, tech-enabled healthcare models at the early-growth stage. Funds I and II backed over 18 companies, including Qure.ai, Medikabazaar, THB, Wysa, Ekincare, Redcliffe Labs, GoApptiv, and Strand Life Sciences. With Fund III, Quadria takes a step toward establishing a broader healthcare investment franchise. Dr. Amit Varma, Abrar Mir, and Sunil Thakur will assume full ownership and control of the platform following its separation from KOIS. A significant portion of the existing investment and committee team will remain involved in managing current portfolio investments. Quadria intends to leverage its global and domestic institutional investor network to support the fund and create scaled impact. The firm recently closed Quadria Capital Fund III at $1.07 billion, backed by leading global institutions. Founded in 2012, Quadria Capital manages over $4 billion in assets across 27 investments in South and Southeast Asia, including India, Vietnam, Indonesia, Malaysia, and Singapore. The firm aims to generate sustainable value by partnering with high-impact healthcare businesses and delivering strong investor returns.

SoftBank turns around in FY25: Clocks $7.4 Bn profit, bets big on AI and chips

EntrackrEntrackr · 2m ago
SoftBank turns around in FY25: Clocks $7.4 Bn profit, bets big on AI and chips
Medial

SoftBank Group has posted a net profit of $7.4 billion in FY25, marking a sharp reversal from a loss of $1.4 billion in the previous year. The turnaround follows aggressive bets on artificial intelligence and semiconductor plays. The Japanese conglomerate’s revenue rose 7.2% year-on-year to $45.97 billion, while income before tax jumped to $10.8 billion from just $367.5 million last year. SoftBank attributed the gain to a $23.5 billion investment profit from holdings in Alibaba, T-Mobile, and Deutsche Telekom. Its investment business, led by founder Masayoshi Son, recorded ¥3.41 trillion ($21.7 billion) in gains. This included ¥1.88 trillion ($11.94 billion) from Alibaba and ¥1.35 trillion ($8.58 billion) from T-Mobile. However, these were partially offset by a ¥2.03 trillion derivative loss, largely due to prepaid forward contracts using Alibaba shares. The performance of the Vision Fund segment remained mixed. While Vision Fund 1 clocked a ¥940 billion gain ($5.97 billion), Vision Fund 2 posted a loss of ¥526 billion ($3.34 billion). The group also incurred a ¥491.8 billion ($3.17 billion) charge related to third-party investor interests in the Vision Funds. A large part of Vision Fund 2’s losses came from a drop in the value of companies like Ola and Swiggy, which saw their stock prices and valuations fall. SoftBank said the value of its publicly listed investments under Vision Fund 2 fell by 21.7% in the last quarter. Meanwhile, SoftBank is doubling down its investment in AI infrastructure. It has committed up to $30 billion to OpenAI Global and is acquiring US-based chipmaker Ampere for $6.5 billion. The group also launched the “Stargate” project — a $500 billion initiative to build large-scale AI data centers. Despite the return to profitability, SoftBank flagged macro uncertainties including FX volatility, regulatory risks, and performance variance in its private market bets. The company will propose a year-end dividend of ¥22 ($0.14) per share, taking the full-year payout to ¥44 ($0.28), unchanged from last year.

Download the medial app to read full posts, comements and news.